TEKMIRA PHARMACEUTICALS CORP - COM NEW (TKMR)

CUSIP: 87911B209

Q1 2014 13F Holders as of 31 Mar 2014

Type / Class
Equity / COM NEW
Total 13F shares
8,108,246
Share change
+3,115,813
Total reported value
$174,309,000
Put/Call ratio
38%
Price per share
$21.49
Number of holders
50
Value change
+$79,336,731
Number of buys
40
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 87911B209?
CUSIP 87911B209 identifies TKMR - TEKMIRA PHARMACEUTICALS CORP - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TEKMIRA PHARMACEUTICALS CORP - COM NEW (TKMR) as of Q1 2014

As of 31 Mar 2014, TEKMIRA PHARMACEUTICALS CORP - COM NEW (TKMR) was held by 50 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,108,246 shares. The largest 10 holders included FRANKLIN RESOURCES INC, BANK OF MONTREAL /CAN/, WELLS FARGO & COMPANY/MN, BAKER BROS. ADVISORS LP, ALLIANCEBERNSTEIN L.P., MARXE AUSTIN W & GREENHOUSE DAVID M, BlackRock Advisors LLC, BOGLE INVESTMENT MANAGEMENT L P /DE/, SIGMA CAPITAL MANAGEMENT LLC, and MORGAN STANLEY. This page lists 50 institutional shareholders reporting positions in this security for the Q1 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.